Literature DB >> 25399212

Nosocomial infections in ambulances and effectiveness of ambulance fumigation techniques in Saudi Arabia. Phase I study.

Daifallah Alrazeeni1, Mohammed S Al Sufi.   

Abstract

OBJECTIVES: To evaluate infection control and the incidence of bacterial pathogens in Emergency Medical Service (EMS) ambulances in Riyadh, Saudi Arabia. The effectiveness of fumigation techniques used for these ambulances to minimize the spread of infection to transported patients and pre-hospital care providers was also assessed.
METHODS: Based on previous literature review indicating a higher propensity of microbial load, 3 areas within the ambulance, such as, stretcher handle, oxygen flow meter knob, and interior handle of the rear door were selected for specimen collection. Swab samples were collected both in the day and night shift, after the intended disinfection and cleaning (before and after fumigation). Micro-organisms were identified using standard procedures. This phase-I study was conducted at the Emergency Medical Services Department, Prince Sultan Bin AbdulAziz College of Emergency Medical Services, Al Malaz, King Saud University, Riyadh, Saudi Arabia between October and November 2013, wherein a total of 10 ambulances from the Saudi Red Crescent Authority in Riyadh were selected for inclusion in the study.
RESULTS: The specimens from all 10 ambulances showed similar results. In post disinfection and before fumigation, swab samples showed positive cultures that grew moderate to large quantities of environmental and skin flora. However, almost all organisms were susceptible to the fumigation technique.
CONCLUSION: This study confirms the importance of evaluating the frequency and efficiency of various fumigation techniques as an ambulance is a potential reservoir for microbial transmission to patients and staff.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25399212      PMCID: PMC4362147     

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  11 in total

1.  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002.

Authors: 
Journal:  Am J Infect Control       Date:  2002-12       Impact factor: 2.918

2.  A preliminary investigation into bacterial contamination of Welsh emergency ambulances.

Authors:  Y Nigam; J Cutter
Journal:  Emerg Med J       Date:  2003-09       Impact factor: 2.740

Review 3.  Systematic review of economic analyses of health care-associated infections.

Authors:  Patricia W Stone; Deborah Braccia; Elaine Larson
Journal:  Am J Infect Control       Date:  2005-11       Impact factor: 2.918

4.  An assessment of the prevalence of pathogenic microorganisms in the rotor wing air ambulance: one program's findings.

Authors:  Mark Galtelli; Clyde Deschamp; Jason Rogers
Journal:  Air Med J       Date:  2006 Mar-Apr

5.  Bacterial pathogens in ambulances: results of unannounced sample collection.

Authors:  Donald W Alves; Richard A Bissell
Journal:  Prehosp Emerg Care       Date:  2008 Apr-Jun       Impact factor: 3.077

6.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

Review 7.  Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections.

Authors:  Todd J Kowalski; Elie F Berbari; Douglas R Osmon
Journal:  Mayo Clin Proc       Date:  2005-09       Impact factor: 7.616

Review 8.  The epidemiology of colonization.

Authors:  W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1996-01       Impact factor: 3.254

9.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.

Authors:  D Pittet; D Tarara; R P Wenzel
Journal:  JAMA       Date:  1994-05-25       Impact factor: 56.272

10.  Can methicillin-resistant Staphylococcus aureus be found in an ambulance fleet?

Authors:  Chad E Roline; Christina Crumpecker; Thomas M Dunn
Journal:  Prehosp Emerg Care       Date:  2007 Apr-Jun       Impact factor: 3.077

View more
  7 in total

Review 1.  The Emergency Medical Service Microbiome.

Authors:  Andrew J Hudson; Graeme D Glaister; Hans-Joachim Wieden
Journal:  Appl Environ Microbiol       Date:  2018-02-14       Impact factor: 4.792

2.  Metagenomic characterization of ambulances across the USA.

Authors:  Niamh B O'Hara; Harry J Reed; Ebrahim Afshinnekoo; Donell Harvin; Nora Caplan; Gail Rosen; Brook Frye; Stephen Woloszynek; Rachid Ounit; Shawn Levy; Erin Butler; Christopher E Mason
Journal:  Microbiome       Date:  2017-09-22       Impact factor: 14.650

3.  Ambulance vehicles as a source of multidrug-resistant infections: a multicenter study in Assiut City, Egypt.

Authors:  Mohamed A El-Mokhtar; Helal F Hetta
Journal:  Infect Drug Resist       Date:  2018-04-24       Impact factor: 4.003

4.  A two-armed, randomised, controlled exploratory study of adding the AmbuGard cleaning system to normal deep-cleaning procedures in a regional ambulance service.

Authors:  Graham McClelland; Karl Charlton; Jacqueline Mains; Karen Millican; Caroline Cullerton
Journal:  Br Paramed J       Date:  2020-09-01

5.  The impact of an ambulance vehicle preparation service on the presence of bacteria: a service evaluation.

Authors:  Mo Mackenzie; Richard Pilbery
Journal:  Br Paramed J       Date:  2019-03-01

6.  Prehospital infection control and prevention in Denmark: a cross-sectional study on guideline adherence and microbial contamination of surfaces.

Authors:  Heidi Storm Vikke; Matthias Giebner; Hans Jørn Kolmos
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-09-05       Impact factor: 2.953

Review 7.  EMS Disease Exposure, Transmission, and Prevention: a Review Article.

Authors:  Colton Bitely; Brian Miller; Jonathan Glauser
Journal:  Curr Emerg Hosp Med Rep       Date:  2019-10-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.